Navigation Links
Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
Date:3/31/2008

t

with our second generation technologies.

Progressed our preclinical programs in regenerative therapeutics,

neurodegenerative disease and molecular imaging.

-- Data from a rodent study designed to measure the levels of Inosine in

the brain during intravenous infusion of high concentrations of Inosine

were presented at the American Society for Experimental

NeuroTherapeutics (ASENT). This study showed that, when administered

intravenously using a new, high concentration formulation of Inosine,

Inosine levels in the brain increased more than 600% over baseline

levels. Inosine is a nerve regenerative factor that has been shown to

promote axon outgrowth in neurons and has potential to be used to treat

CNS disorders such as spinal cord injury, stroke, and traumatic brain

injury.

-- Findings from a study to determine brain bioavailability following oral

administration of three of Alseres' highly-selective dopamine

transporter (DAT) blockers were also presented at the ASENT meeting.

The data presented showed that all three of the Company's DAT blockers

given orally were rapidly absorbed into the blood and the brain and

provided favorable brain-to-blood plasma ratios.

-- Working with our scientific collaborators, we initiated a series of

comparative studies in which other of our regenerative technologies,

including Inosine, Oncomodulin and other compounds, are being tested in

parallel in a series of models of CNS disorders to assess their

potential to enhance nerve repair. If successful, these studies may

enable the most promising candidates and indications to be taken

forward in development.

-- We are also evaluating our Rho inhibitors in animal models to assess

their ability to stimulate cells to regenerate bone. It is estimate
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call
2. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
3. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
4. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
5. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
6. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
7. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
8. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
9. Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations
10. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
11. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 ... Markets ( http://www.researchandmarkets.com/research/cmbgcv/north_american ) has announced ... American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes ... Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, ... to 2017" report to their ...
(Date:6/18/2013)... PathoGenetix, Inc. , a commercial-stage ... strain typing, announced today that John A. Luckey, ... President of Engineering. Dr. Luckey will lead technology ... Microbial Genotyping System . The fully automated RESOLUTION ... kits, database and software, will be commercially available ...
(Date:6/18/2013)... City, UT (PRWEB) June 18, 2013 ... next generation imaging and in vitro diagnostic (IVD) biomarkers, ... with NuView’s novel urine screen in development for the ... study was presented in an oral presentation at the ... and Molecular Imaging (SNMMI) in Vancouver, Canada on Sunday, ...
Breaking Biology Technology:DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 2North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017 3PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 3
... EUSA,s Focus on Late-Stage and Marketed ... ... Pennsylvania and OXFORD, England, May 1 ,EUSA Pharma Inc (,EUSA,), ... critical care, today announced that,it has divested its monoclonal antibody ...
... in Milan and Northeast Georgia Medical Center in ... Gainesville, Stereotaxis to ... ... May 1 Stereotaxis, Inc. (Nasdaq:,STXS) announced today the first ever bi-directional live case ...
... April 30 Amylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) ... Morgan Stanley Global Healthcare Unplugged Conference in Key,Biscayne, FL ... / 12:00 p.m. PT.,Previously, the presentation had been scheduled ... Bradbury, President and Chief Executive Officer of,Amylin Pharmaceuticals, will ...
Cached Biology Technology:EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product 2EUSA Pharma Divests Monoclonal Antibody Research Business and Early-Stage Oncology Product 3Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network 2Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network 3Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network 4
(Date:6/18/2013)... 2013 The herbal extract of a yellow-flowered mountain ... increase the lifespan of fruit fly populations by an ... , But it,s how Rhodiola rosea ... grabbed the attention of study leaders Mahtab Jafari and ... in a manner completely unrelated to dietary restriction and ...
(Date:6/17/2013)... Boston, MA Women in the U.S. exposed to high ... as likely to have a child with autism as women ... new study from Harvard School of Public Health (HSPH). It ... autism and air pollution across the U.S. , "Our findings ... of the women in our study lived in areas where ...
(Date:6/17/2013)... professors in Wayne State University,s Department of Physics ... Research Experience for Undergraduates (REU) program. This program ... cutting-edge research in astrophysics, and in particle and ... Ph.D., professor of physics in Wayne State,s College ... director of the grant, the student participants will ...
Breaking Biology News(10 mins):Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2Wayne State welcomes undergraduates from around the US for physics research experience 2
... that differences in bacterial colonization of the infant gut in ... of genes involved in the infant,s immune system. The ... open access journal Genome Biology , is an Editor,s ... Illinois, Texas A&M University, Miami University, and University of Arkansas ...
... scientists from the National University of Singapore,s (NUS) Department of ... compound a compound that is undergoing preclinical trials as ... and stop them from growing into a tumour. This drug-led ... time a research group has provided evidence showing how a ...
... A clear change in salinity has been detected ... in the global rainfall and evaporation cycle., In a ... scientists from the Commonwealth Scientific and Industrial Research Organisation ... changing patterns of salinity in the global ocean during ...
Cached Biology News:Breast-fed babies' gut microbes contribute to healthy immune systems 2Novel discovery by NUS scientists paves the way for more effective treatment of cancers 2Earth's water cycle intensifying with atmospheric warming 2
... UVP's HybriCycler Hybridization Oven with circular ... bottles and tubes. HC-3000 HybriCycler Oven features ... Non-skid leveling feet balance the unit., ... durable acrylic, carousel is ,easily removable ...
... The KingFisher magnetic particle based purification ... and DNA/RNA from any sample. They offer ... family comprises three systems- KingFisher, KingFisher mL ... 20 - 1000 l. Each system consists ...
... for efficient drying down of synthetic oligos. ... and a post-trap with ammonia neutralizing solution ... samples in ammonium hydroxide., , Complete ... , Comes standard with a ...
... the standard for sample concentration and drying. ... uses a combination of centrifugal force, heat and ... run. , SC210A comes equipped with:, ... chemical compatibility ...
Biology Products: